News

Filter

GW Pharma and Almirall extend Sativex deal to Mexico

15-03-2012

UK-based GW Pharmaceuticals (AIM: GWP) announces that it has signed an amendment to its cannabis-based…

AlmirallFinancialGW PharmaceuticalsLicensingNeurologicalPharmaceuticalSativexSouth America

Novartis drops Ph III Tasigna trial for GIST; in-licenses Sativex; and reports new Gilenya data

11-04-2011

In what has been a couple of busy and mixed news days for Swiss drug major Novartis (NOVN: VX), this…

AfinitorGilenyaGW PharmaceuticalsLicensingNeurologicalNovartisOncologyPharmaceuticalRegulationResearchSativexTasigna

Back to top